References
Akira
S
,
Taga
T
and
Kishimoto
T
(1993) Interleukin-6 in biology and medicine. Advances in Immunology
54: 1–78.
Alber
G
,
Al‐Robaiy
S
,
Kleinschek
M
et al. (2006) Induction of immunity and inflammation by interleukin‐12 family members. Ernst Schering Research Foundation Workshop
56: 107–127.
Ambrus
J
Jr
,
Pippin
J
,
Joseph
A
et al. (1993) Identification of a cDNA for human high molecular weight B cell growth factor (HMW‐BCGF). Proceedings of the National Academy of Sciences of the USA
90: 6330–6334.
Annunziato
F
,
Cosmi
L
,
Liotta
F
,
Maggi
E
and
Romagnani
S
(2009) Type 17 T helper cells – origins, features and possible roles in rheumatoid arthritis. Nature Reviews Rheumatology
5: 325–331.
Arend
WP
,
Palmer
G
and
Gabay
C
(2008) IL‐1, IL‐18 and IL‐33 families of cytokines. Immunological Reviews
223: 20–38.
Aujla
SJ
and
Kolls
JK
(2009) IL‐22: a critical mediator in mucosal host defense. Journal of Molecular Medicine
87: 451–454.
Azuma
YT
,
Nakajima
H
and
Takeuchi
T
(2011) IL‐19 as a potential therapeutic in autoimmune and inflammatory diseases. Current Pharmaceutical Design
17: 3776–3780.
Baggiolini
M
,
Dewald
B
and
Moser
B
(1994) Interleukin‐8 and related chemotactic cytokines – CXC and CC chemokines. Advances in Immunology
55: 97–179.
Banchereau
J
,
Pascual
V
and
O'Garra
A
(2012) From IL‐2 to IL‐37: the expanding spectrum of anti‐inflammatory cytokines. Nature Immunology
13: 925–931.
Bhattacharjee
A
,
Shukla
M
,
Yakubenko
VP
et al. (2012) IL‐4 and IL‐13 employ discrete signalling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radical Biology and Medicine
54: 1–16.
Boraschi
D
and
Dinarello
CA
(2006) IL‐18 in autoimmunity: a review. European Cytokine Network
17: 224–252.
Boulay
J‐L
and
Paul
W
(1992) The interleukin‐4‐related lymphokines and their binding to haematopoietin receptors. Journal of Biological Chemistry
267: 20525–20528.
Boyman
O
and
Sprent
J
(2012) The role of interleukin‐2 during homeostasis and activation of the immune system. Nature Reviews Immunology
12: 180–190.
Broughton
SE
,
Dhagat
U
,
Hercus
TR
et al. (2012) The GM‐CSF/IL‐3/IL‐5 cytokine receptor family: from ligand recognition to initiation of signalling. Immunological Reviews
250: 271–302.
Budagian
V
,
Bulanova
E
,
Paus
R
and
Bulfone‐Paus
(2006) IL‐15/IL‐15 receptor biology: a guided tour through an expanding universe. Cytokine and Growth Factor Reviews
17: 259–280.
Camporeale
A
and
Poli
V
(2012) IL‐6, IL‐17 and STAT3: a holy trinity in autoimmunity? Frontiers in Bioscience
17: 2306–2326.
Chihara
T
,
Suzu
S
,
Hassan
R
et al. (2010) IL‐34 and M‐CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death and Differentiation
17: 1917–1927.
Cohen
J
(2012) Inhibition of interleukin‐5 for the treatment of eosinophilic diseases. Discovery Medicine
13: 305–312.
Collison
LW
,
Delgoffe
GM
,
Guy
CS
et al. (2012) The composition and signalling of the IL‐35 receptor are unconventional. Nature Immunology
13: 290–299.
Corfe
SA
and
Paige
CJ
(2012) The many roles of IL‐7 in B cell development; mediator of survival, proliferation and differentiation. Seminars in Immunology
24: 198–208.
Cornelissen
C
,
Lüscher-Firzlaff
J
,
Baron
JM
and
Lüscher
B
(2012) Signaling by IL‐31 and its functional consequences. European Journal of Cell Biology
91: 552–566.
Croce
M
,
Orengo
AM
,
Azzarone
B
and
Ferrini
S
(2012) Immunotherapeutic applications of IL‐15. Immunotherapy
4: 957–969.
Croxford
AL
,
Mair
F
and
Becher
B
(2012) IL‐23: one cytokine in control of autoimmunity. European Journal of Immunology
42: 2263–2273.
Cruikshank
W
and
Little
F
(2008) Interleukin‐16: the ins and outs of regulating T‐cell activation. Critical Reviews in Immunology
28: 467–483.
De Vries
JE
(1996) Molecular and biological characteristics of interleukin‐13. Chemical Immunology
63: 204–218.
Di Cesare
A
,
Di Meglio
P
and
Nestle
FO
(2009) The IL‐23/Th17 axis in the immunopathogenesis of psoriasis. Journal of Investigative Dermatology
129: 1339–1350.
Di Sabatino
A
,
Calarota
SA
,
Vidali
F
,
Macdonald
TT
and
Corazza
GR
(2011) Role of IL‐15 in immune‐mediated and infectious diseases. Cytokine and Growth Factor Reviews
22: 19–33.
Dinarello
CA
(2009) Immunological and inflammatory functions of the interleukin‐1 family. Annual Review of Immunology
27: 519–550.
Dinarello
CA
,
Arend
W
,
Sims
J
et al. (2010) IL‐1 family nomenclature. Nature Immunology
11: 973.
Dinarello
CA
,
Simon
A
and
van der
Meer
JW
(2012) Treating inflammation by blocking interleukin‐1 in a broad spectrum of diseases. Nature Reviews Drug Discovery
11: 633–652.
Donnelly
RP
and
Kotenko
SV
(2010) Interferon‐lambda: a new addition to an old family. Journal of Interferon and Cytokine Research
30: 555–564.
Donnelly
RP
,
Sheikh
F
,
Kotenko
SV
and
Dickensheets
H
(2004) The expanded family of class II cytokines that share the IL‐10 receptor‐2 (IL‐10R2) chain. Journal of Leukocyte Biology
76: 314–321.
Donnelly
RP
,
Sheikh
F
,
Dickensheets
H
et al. (2010) Interleukin‐26: an IL‐10‐related cytokine produced by Th17 cells. Cytokine and Growth Factor Reviews
21: 393–401.
Donnelly
RP
,
Dickensheets
H
and
O'Brien
TR
(2011) Interferon‐lambda and therapy for chronic hepatitis C virus infection. Trends in Immunology
32: 443–450.
Du
X
and
Williams
D
(1994) Interleukin‐11: a multifunctional growth factor derived from the hematopoietic microenvironment. Blood
83: 2023–2030.
Duvallet
E
,
Semerano
L
,
Assier
E
,
Falgarone
G
and
Boissier
MC
(2011) Interleukin‐23: a key cytokine in inflammatory diseases. Annals of Medicine
43: 503–511.
Ely
LK
,
Fischer
S
and
Garcia
KC
(2009) Structural basis of receptor sharing by the interleukin‐17 cytokines. Nature Immunology
10: 1245–1251.
Felaco
P
,
Castellani
ML
,
De Lutiis
MA
et al. (2009) IL‐32: a newly‐discovered proinflammatory cytokine. Journal of Biological Regulators and Homeostatic Agents
23: 141–147.
Fickenscher
H
,
Hör
S
,
Küpers
H
et al. (2003) The interleukin‐10 family of cytokines. Trends in Immunology
23: 89–96.
Gaffen
SL
(2009) Structure and signalling in the IL‐17 receptor family. Nature Reviews Immunology
9: 556–567.
Gaffen
SL
(2011) Recent advances in the IL‐17 cytokine family. Current Opinion in Immunology
23: 613–619.
Gallagher
G
(2010) Interleukin‐19: multiple roles in immune regulation and disease. Cytokine and Growth Factor Reviews
21: 345–352.
Germann
T
and
Rüde
E
(1995) Interleukin‐12. International Archives of Allergy and Immunology
108: 103–112.
Glass
WG
,
Sarisky
RT
and
Del Vecchio
AM
(2006) Not‐so‐sweet sixteen: The role of IL‐16 in infectious and immune‐mediated inflammatory diseases. Journal of Interferon and Cytokine Research
26: 511–520.
Guo
Y
,
Xu
F
,
Lu
T
,
Duan
Z
and
Zhang
Z
(2012) Interleukin‐6 signalling pathway in targeted therapy for cancer. Cancer Treatment Reviews
38: 904–910.
Hedrich
CM
and
Bream
JH
(2010) Cell type‐specific regulation of IL‐10 expression in inflammation and disease. Immunologic Research
47: 185–206.
Heinhuis
B
,
Netea
MG
,
van den
Berg
WB
,
Dinarello
CA
and
Joosten
LA
(2012) Interleukin‐32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell death. Cytokine
60: 321–327.
Heinrich
PC
,
Behrmann
I
,
Haan
S
et al. (2003) Principles of interleukin (IL)‐6‐type cytokine signalling and its regulation. Biochemical Journal
374: 1–20.
Hershey
GK
(2003) IL‐13 receptors and signalling pathways. Journal of Allergy and Clinical Immunology
111: 677–690.
Hofmann
SR
,
Rösen-Wolff
A
,
Tsokos
GC
and
Hedrich
CM
(2012) Biological properties and regulation of IL‐10 related cytokines and their contribution to autoimmune disease and tissue injury. Clinical Immunology
143: 116–127.
Hunter
CA
(2005) New IL‐12 family members: IL‐23 and IL‐27, cytokines with divergent functions. Nature Reviews Immunology
5: 521–531.
Jones
LL
and
Vignali
DA
(2011) Molecular interactions within the IL‐6/IL‐12 cytokine/receptor superfamily. Immunologic Research
51: 5–14.
Kishimoto
T
,
Akira
S
,
Narazaki
M
and
Taga
T
(1995) Interleukin‐6 family of cytokines and gp130. Blood
86: 1243–1254.
Kouro
T
and
Takatsu
K
(2009) IL‐5‐ and eosinophil‐mediated inflammation: from discovery to therapy. International Immunology
21: 1303–1309.
Koyasu
S
and
Moro
K
(2011) Type 2 innate immune responses and the natural helper cell. Immunology
132: 475–481.
Langowski
JL
,
Zhang
X
,
Wu
L
et al. (2006) IL‐23 promotes tumour incidence and growth. Nature
442: 461–465.
Langrish
CL
,
McKenzie
BS
,
Wilson
NJ
et al. (2004) IL‐12 and IL‐23: master regulators of innate and adaptive immunity. Immunological Reviews
202: 96–105.
Leng
RX
,
Pan
HF
,
Tao
JH
and
Ye
DQ
(2011) IL‐19, IL‐20 and IL‐24: potential therapeutic targets for autoimmune diseases. Expert Opinion on Therapeutic Targets
15: 119–126.
Li
Z
,
Chen
L
and
Qin
Z
(2009) Paradoxical roles of IL‐4 in tumor immunity. Cellular and Molecular Immunology
6: 415–422.
Liao
W
,
Lin
J‐X
and
Leonard
WJ
(2011) IL‐2 family cytokines: new insights into the complex roles of IL‐2 as a broad regulator of T helper cell differentiation. Current Opinion in Immunology
23: 598–604.
Liew
FY
(2012) IL‐33: a Janus cytokine. Annals of the Rheumatic Diseases
71 (Suppl. 2): i101–i104.
Lin
JX
,
Migone
TS
,
Tsang
M
et al. (1995) The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL‐2, IL‐4, IL‐7, IL‐13, and IL‐15. Immunity
2: 331–339.
Ma
A
,
Koka
R
and
Burkett
P
(2006) Diverse functions of IL‐2, IL‐15, and IL‐7 in lymphoid homeostasis. Annual Reviews of Immunology
24: 657–679.
Ma
X
,
Lin
WY
,
Chen
Y
et al. (2012) Structural basis for the dual recognition of helical cytokines IL‐34 and CSF‐1 by CSF‐1R. Structure
20: 676–687.
Mackall
CL
,
Fry
TJ
and
Gresse
RE
(2011) Harnessing the biology of IL‐7 for therapeutic application. Nature Reviews Immunology
11: 330–342.
Martinez‐Moczygemba
M
and
Huston
DP
(2003) Biology of common beta receptor‐signaling cytokines: IL‐3, IL‐5 and GM‐CSF. Journal of Allergy and Clinical Immunology
112: 653–665.
Mehta
DS
,
Wurster
AL
and
Grusby
MJ
(2004) Biology of IL‐21 and the IL‐21 receptor. Immunological Reviews
202: 84–95.
Mitchell
J
,
Dimov
V
and
Townley
RG
(2010) IL‐13 and the IL‐13 receptor as therapeutic targets for asthma and allergic disease. Current Opinion in Investigational Drugs
11: 527–534.
Moissec
P
,
Torn
T
and
Kuchroo
VK
(2009) Interleukin‐17 and type 17 helper T cells. New England Journal of Medicine
361: 888–898.
Mudigonda
P
,
Mudigonda
T
,
Feneran
AN
et al. (2012) Interleukin‐23 and interleukin‐17: importance in pathogenesis and therapy of psoriasis. Dermatology Online Journal
18(10): 1.
Mueller
TD
,
Zhang
JL
,
Sebald
W
and
Duschl
A
(2002) Structure, binding, and antagonists in the IL‐4/IL‐13 receptor system. Biochimica et Biophysica Acta
1592: 237–250.
Navarro‐Millan
I
,
Singh
JA
and
Curtis
JR
(2012) Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin‐6 receptor. Clinical Therapeutics
34: 788–802.
Ning
Y
and
Lenz
HJ
(2012) Targeting IL‐8 in colorectal cancer. Expert Opinion on Therapeutic Targets
16(5): 491–497.
Nold
F
,
Nold-Petry
CA
,
Zepp
JA
et al. (2010) IL‐37 is a fundamental inhibitor of innate immunity. Nature Immunology
11: 1014–1022.
Oh
CK
,
Raible
D
,
Geba
GP
and
Molfino
NA
(2011) Biology of the interleukin‐9 pathway and its therapeutic potential for the treatment of asthma. Inflammation and Allergy – Drug Targets
10: 180–186.
Ouyang
W
,
Rutz
S
,
Crellin
NK
,
Valdez
PA
and
Hymowitz
SG
(2011) Regulation and functions of the IL‐10 family of cytokines in inflammation and disease. Annual Review of Immunology
29: 71–109.
Palmer
MJ
,
Mahajan
VS
,
Trajman
L
et al. (2008) Perspectives on the quantitative immunobiology of the IL‐7 signaling network. Cellular and Molecular Immunology
5: 79–89.
Pope
RM
and
Shahara
S
(2012) Possible roles of IL‐12‐family cytokines in rheumatoid arthritis. Nature Reviews Rheumatology
9(4): 252–256.
Power
C
and
Wells
T
(1996) Cloning and characterization of human chemokine receptors. Trends in Pharmacological Sciences
17: 209–213.
Putoczki
T
and
Ernst
M
(2010) More than a sidekick: the IL‐6 family cytokine IL‐11 links inflammation to cancer. Journal of Leukocyte Biology
88: 1109–1117.
Sabat
R
(2010) IL‐10 family of cytokines. Cytokine and Growth Factor Reviews
21: 315–324.
Sabat
R
,
Grütz
G
,
Warszawska
K
et al. (2010) Biology of interleukin‐10. Cytokine and Growth Factor Reviews
21: 331–344.
Sahoo
M
,
Ceballos-Olvera
I
,
del
Barrio
L
and
Re
F
(2011) Role of the inflammasome, IL‐1β, and IL‐18 in bacterial infections. Scientific World Journal
11: 2037–2050.
Sasson
SC
,
Zaunders
JJ
and
Kelleher
AD
(2006) The IL‐7/IL‐7R receptor axis: understanding its central role in T‐cell homeostasis and the challenges facing its utilization as a novel therapy. Current Drug Targets
7: 1571–1582.
Sato
T
,
Terai
M
,
Tamura
Y
et al. (2011) Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunologic Research
51: 170–182.
Schwertschlag
US
,
Trepicchio
WL
,
Dykstra
KH
et al. (1999) Hematopoietic, immunomodulatory and epithelial effects of interleukin‐11. Leukemia
13: 1307–1315.
Sims
JE
and
Smith
DE
(2010) The IL‐1 family: regulators of immunity. Nature Reviews Immunology
10: 89–102.
Sonkoly
E
,
Muller
A
,
Lauerma
AI
et al. (2006) IL‐31: a new link between T cells and pruritis in atopic skin inflammation. Journal of Allergy and Clinical Immunology
117: 411–417.
Sonnenberg
GF
,
Fouser
LA
and
Artis
D
(2010) Functional biology of the IL‐22‐IL‐22R pathway in regulating immunity and inflammation at barrier surfaces. Advances in Immunology
107: 1–29.
Spolski
R
and
Leonard
WJ
(2008) Interleukin‐21: basic biology and implications for cancer and autoimmunity. Annual Review of Immunology
26: 51–79.
Steel
JC
,
Waldmann
TA
and
Morris
JC
(2012) Interleukin‐15 biology and its therapeutic implications in cancer. Trends in Pharmacological Sciences
33: 35–41.
Stumhofer
JS
,
Tait
ED
,
Quinn
WJ
3rd
et al. (2010) A role for IL‐27p28 as an antagonist of gp130‐mediated signalling. Nature Immunology
11: 1119–1126.
Sugamura
K
,
Asao
H
,
Kondo
M
et al. (1995) The common γ‐chain for multiple cytokine receptor. Advances in Immunology
59: 225–277.
Tanaka
T
and
Kishimoto
T
(2012) Immunotherapeutic implication of IL‐6 blockade. Immunotherapy
4: 87–105.
Tripodi
D
,
Conti
F
,
Rosati
M
et al. (2012) IL‐36 a new member of the IL‐1 family cytokines. Journal of Biological Regulators and Homeostatic Agents
26: 7–14.
Trivella
DB
,
Ferreira-Júnior
JR
,
Dumoutier
L
,
Renauld
JC
and
Polikarpov
I
(2010) Structure and function of interleukin‐22 and other members of the interleukin‐10 family. Cellular and Molecular Life Sciences
67: 2909–2935.
Van de Veerdonk
FL
(2012) IL‐38 binds to the IL‐36 receptor and has biological effects on immune cells similar to the IL‐36 receptor antagonist. Proceedings of the National Academy of Sciences of the USA
109: 3001–3005.
Vignali
DAA
and
Kuchroo
VK
(2012) IL‐12 family cytokines: immunological playmakers. Nature Immunology
13: 722–728.
Vigne
S
,
Palmer
G
,
Lamacchia
C
et al. (2011) IL‐36R ligands are potent regulators of dendritic and T cells. Blood
118: 5813–5823.
Waldmann
TA
(2006) The biology of interleukin‐2 and interleukin‐15: implications for cancer therapy and vaccine design. Nature Reviews Immunology
6: 595–601.
Waugh
DJ
and
Wilson
C
(2008) The interleukin‐8 pathway in cancer. Clinical Cancer Research
14: 6735–6741.
Weaver
CT
,
Hatton
RD
,
Mangan
PR
and
Harrington
LE
(2007) IL‐17 family cytokines and expanding diversity of effector T cell lineages. Annual Review of Immunology
25: 821–852.
Whitworth
JM
and
Alvarez
RD
(2011) Evaluating the role of IL‐12 based therapies in ovarian cancer: a review of the literature. Expert Opinion on Biological Therapy
11: 751–762.
Xu
M
,
Mizoguchi
I
,
Morishima
N
et al. (2010) Regulation of antitumor immune responses by the IL‐12 family cytokines, IL‐12, IL‐23, and IL‐27. Clinical and Developmental Immunology. DOI: 10.1155/2010/832454.
Xu
S
and
Cao
X
(2010) Interleukin‐17 and its expanding biological functions. Cellular and Molecular Immunology
7: 164–174.
Yi
JS
,
Cox
MA
and
Zajac
AJ
(2010) Interleukin‐21: a multifunctional regulator of immunity to infections. Microbes and Infection
12: 1111–1119.
Yuzhalin
AE
and
Kufikhin
AG
(2012) Interleukin‐12: clinical usage and molecular markers of cancer susceptibility. Growth Factors
30: 176–191.
Zaghi
D
,
Krueger
GG
and
Callis Duffin
K
(2012) Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis. Journal of Drugs in Dermatology
11: 160–167.
Zdanov
A
(2011) Structural analysis of cytokines comprising the IL‐10 family. Cytokine and Growth Factor Reviews
21: 325–330.
Zenewicz
LA
and
Flavell
RA
(2011) Recent advances in IL‐22 biology. International Immunology
23: 159–163.
Zhang
Q
,
Putheti
P
,
Zhou
Q
,
Liu
Q
and
Gao
W
(2008) Structures and biological functions of IL‐31 and IL‐31 receptors. Cytokine and Growth Factor Reviews
19: 347–356.
Zhang
X
,
Angkasekwinai
P
,
Dong
C
and
Tang
H
(2011) Structure and function of interleukin‐17 family cytokines. Protein Cell
2: 26–40.
Further Reading
Aggarwal
BB
(ed.) (1992) Human Cytokines: Handbook for Basic and Clinical Research, vol. 1. Oxford: Blackwell Science.
Aggarwal
BB
(ed.) (1996) Human Cytokines: Handbook for Basic and Clinical Research, vol. 2. Oxford: Blackwell Science.
Ibelgaufts
H
(2013) Cytokines & Cells Online Pathfinder Encyclopaedia (COPE). http://copewithcytokines.de/cope.cgi
Meager
T
(1998) The Molecular Biology of Cytokines. Chichester, UK: John Wiley.
Mire‐Sluis
AR
and
Thorpe
R
(eds) (1998) Cytokines. London: Academic Press.
Thomson
AW
(ed.) (1998) The Cytokine Handbook. London: Academic Press.